chrX-63678374-C-A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001353921.2(ARHGEF9):​c.781G>T​(p.Ala261Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,205,322 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.000042 ( 0 hom. 23 hem. )

Consequence

ARHGEF9
NM_001353921.2 missense

Scores

4
4
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 7.32

Publications

1 publications found
Variant links:
Genes affected
ARHGEF9 (HGNC:14561): (Cdc42 guanine nucleotide exchange factor 9) The protein encoded by this gene is a Rho-like GTPase that switches between the active (GTP-bound) state and inactive (GDP-bound) state to regulate CDC42 and other genes. This brain-specific protein also acts as an adaptor protein for the recruitment of gephyrin and together these proteins facilitate receceptor recruitement in GABAnergic and glycinergic synapses. Defects in this gene are the cause of startle disease with epilepsy (STHEE), also known as hyperekplexia with epilepsy, as well as several other types of cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ARHGEF9 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 8
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07881579).
BP6
Variant X-63678374-C-A is Benign according to our data. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256. Variant chrX-63678374-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 210256.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF9NM_001353921.2 linkc.781G>T p.Ala261Ser missense_variant Exon 5 of 10 ENST00000671741.2 NP_001340850.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF9ENST00000671741.2 linkc.781G>T p.Ala261Ser missense_variant Exon 5 of 10 NM_001353921.2 ENSP00000500715.1 A0A5F9ZHY9

Frequencies

GnomAD3 genomes
AF:
0.0000357
AC:
4
AN:
111934
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00150
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000106
AC:
18
AN:
169595
AF XY:
0.000197
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000235
GnomAD4 exome
AF:
0.0000421
AC:
46
AN:
1093333
Hom.:
0
Cov.:
31
AF XY:
0.0000640
AC XY:
23
AN XY:
359489
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26330
American (AMR)
AF:
0.00
AC:
0
AN:
34753
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30056
South Asian (SAS)
AF:
0.000791
AC:
42
AN:
53072
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40204
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4128
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
839592
Other (OTH)
AF:
0.0000653
AC:
3
AN:
45914
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000357
AC:
4
AN:
111989
Hom.:
0
Cov.:
23
AF XY:
0.0000878
AC XY:
3
AN XY:
34179
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30813
American (AMR)
AF:
0.00
AC:
0
AN:
10572
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3545
South Asian (SAS)
AF:
0.00150
AC:
4
AN:
2666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6123
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53194
Other (OTH)
AF:
0.00
AC:
0
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.000181
AC:
22

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 05, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 8 Benign:1
Nov 24, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.24
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;T;.;T;T;T;T;T;T;.;.;T;.;T;T;.;T;.;T;T;.
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D;D;D;D;.;D;.;.;.;D;D;.;D;.;.;D;.;D;D;D;D
M_CAP
Pathogenic
0.54
D
MetaRNN
Benign
0.079
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.37
T
MutationAssessor
Benign
1.2
L;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
7.3
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-2.6
D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.;.;.
REVEL
Uncertain
0.30
Sift
Benign
0.15
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.
Sift4G
Benign
0.087
T;T;T;.;.;.;.;.;.;T;T;T;.;.;.;.;T;T;.;.;.
Polyphen
0.95
P;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.23
MutPred
0.42
Gain of disorder (P = 0.0658);.;Gain of disorder (P = 0.0658);.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;Gain of disorder (P = 0.0658);.;
MVP
0.80
MPC
1.9
ClinPred
0.24
T
GERP RS
5.1
Varity_R
0.70
gMVP
0.76
Mutation Taster
=28/72
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782497496; hg19: chrX-62898254; API